RLAY

Relay Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1812364Held by 5 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

5 managers · Q2 2026 13F

13F bookWeight

Baker Bros. Advisors

Baker Bros. AdvisorsPosition history →

0.27%

+143.7%

$52.9M

$19.96B13F book · 2026-06-30

Duquesne Family Office

Stanley DruckenmillerPosition history →

0.15%

NEW

$6.5M

$4.35B13F book · 2026-06-30

ICONIQ Capital

ICONIQ CapitalPosition history →

0.05%

—

$1.8M

$3.47B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.05%

(32.8%)

$32.6M

$71.32B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.02%

+51.5%

$4.1M

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.